Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Logothetis

Showing results (91-100 of 251) with videos related to

Pageof 26
Sort By:
Cancer Research|July 20, 2007
A secreted isoform of ErbB3 promotes osteonectin expression in bone and enhances the invasiveness of prostate cancer cellsNanyue Chen, Xiang-Cang Ye, Khoi Chu, et al.
The Canadian Journal of Urology|October 28, 2014
Variant prostate carcinoma and elevated serum CA-125Mehmet Asim Bilen, Adriana Reyes, Deb Bhowmick, et al.
Cancer|August 14, 2002
Prostate carcinoma with testicular or penile metastases. Clinical, pathologic, and immunohistochemical featuresShi-Ming Tu, Adriana Reyes, April Maa, et al.
Carcinogenesis|March 28, 2020
Genetic variants in epithelial-mesenchymal transition genes as predictors of clinical outcomes in localized prostate cancerYang Deng, Kunlin Xie, Christopher J Logothetis, et al.
The Prostate|April 2, 2011
Neuroendocrine prostate cancer xenografts with large-cell and small-cell features derived from a single patient's tumor: morphological, immunohistochemical, and gene expression profilesAna Aparicio, Vasiliki Tzelepi, John C Araujo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
NY-ESO-1 DNA vaccine induces T-cell responses that are suppressed by regulatory T cellsSacha Gnjatic, Nasser K Altorki, Derek Ng Tang, et al.
The Lancet. Oncology|October 19, 2007
Addition of estramustine to chemotherapy and survival of patients with castration-refractory prostate cancer: a meta-analysis of individual patient dataKarim Fizazi, Aurelie Le Maitre, Gary Hudes, et al.
Carcinogenesis|August 2, 2002
p21 modulates threshold of apoptosis induced by DNA-damage and growth factor withdrawal in prostate cancer cellsLuis A Martinez, Jun Yang, Elba S Vazquez, et al.
Cancer|January 28, 2003
Phase II trial of cyclophosphamide, vincristine, and dexamethasone in the treatment of androgen-independent prostate carcinomaDanai D Daliani, Vasily Assikis, Shi-Ming Tu, et al.
BJU International|April 3, 2009
Prospective assessment of systemic therapy followed by surgical removal of metastases in selected patients with renal cell carcinomaDanai D Daliani, Nizar M Tannir, Christos N Papandreou, et al.
Pageof 26

Showing results (91-100 of 251) with videos related to

Sort By:
Pageof 26
Cancer Research|July 20, 2007
A secreted isoform of ErbB3 promotes osteonectin expression in bone and enhances the invasiveness of prostate cancer cellsNanyue Chen, Xiang-Cang Ye, Khoi Chu, et al.
The Canadian Journal of Urology|October 28, 2014
Variant prostate carcinoma and elevated serum CA-125Mehmet Asim Bilen, Adriana Reyes, Deb Bhowmick, et al.
Cancer|August 14, 2002
Prostate carcinoma with testicular or penile metastases. Clinical, pathologic, and immunohistochemical featuresShi-Ming Tu, Adriana Reyes, April Maa, et al.
Carcinogenesis|March 28, 2020
Genetic variants in epithelial-mesenchymal transition genes as predictors of clinical outcomes in localized prostate cancerYang Deng, Kunlin Xie, Christopher J Logothetis, et al.
The Prostate|April 2, 2011
Neuroendocrine prostate cancer xenografts with large-cell and small-cell features derived from a single patient's tumor: morphological, immunohistochemical, and gene expression profilesAna Aparicio, Vasiliki Tzelepi, John C Araujo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
NY-ESO-1 DNA vaccine induces T-cell responses that are suppressed by regulatory T cellsSacha Gnjatic, Nasser K Altorki, Derek Ng Tang, et al.
The Lancet. Oncology|October 19, 2007
Addition of estramustine to chemotherapy and survival of patients with castration-refractory prostate cancer: a meta-analysis of individual patient dataKarim Fizazi, Aurelie Le Maitre, Gary Hudes, et al.
Carcinogenesis|August 2, 2002
p21 modulates threshold of apoptosis induced by DNA-damage and growth factor withdrawal in prostate cancer cellsLuis A Martinez, Jun Yang, Elba S Vazquez, et al.
Cancer|January 28, 2003
Phase II trial of cyclophosphamide, vincristine, and dexamethasone in the treatment of androgen-independent prostate carcinomaDanai D Daliani, Vasily Assikis, Shi-Ming Tu, et al.
BJU International|April 3, 2009
Prospective assessment of systemic therapy followed by surgical removal of metastases in selected patients with renal cell carcinomaDanai D Daliani, Nizar M Tannir, Christos N Papandreou, et al.
Pageof 26